Document is current
Any future updates will be listed below
-
Authors
Malenica, Ines
Adam, Julien
Corgnac, Stéphanie https://orcid.org/0000-0002-3014-9178
Mezquita, Laura
Auclin, Edouard
Damei, Isabelle
Grynszpan, Laetitia
Gros, Gwendoline
de Montpréville, Vincent https://orcid.org/0000-0001-7490-4000
Planchard, David
Théret, Nathalie https://orcid.org/0000-0002-5857-7828
Besse, Benjamin
Mami-Chouaib, Fathia https://orcid.org/0000-0001-9685-6011
- License Information
-
More Information
Article History
Received: 9 August 2020
Accepted: 29 July 2021
First Online: 1 September 2021
Competing interests
: B.B.’s sponsored research at Gustave Roussy Cancer Centre: Abbvie, Amgen, AstraZeneca, BeiGene, Blueprint Medicines, BMS, Boehringer Ingelheim, Celgene, Cristal Therapeutics, Daiichi-Sankyo, Eli Lilly, GSK, Ignyta, IPSEN, Inivata, Janssen, Merck KGaA, MSD, Nektar, Onxeo, OSE immunotherapeutics, Pfizer, Pharma Mar, Roche-Genentech, Sanofi, Servier, Spectrum Pharmaceuticals, Takeda, Tiziana Pharma, Tolero Pharmaceuticals. All other authors declare no competing interests.
